QS Investors’s Juno Therapeutics, Inc. JUNO Stock Holding History

QS Investors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,415	Closed	-$110K	–	2009
2017 Q4	$110K	Sell	2,415 -2,085	-46%	-$104K	﹤0.01%	1368
2017 Q3	$202K	Hold	4,500	–	–	﹤0.01%	1219
2017 Q2	$135K	Buy	+4,500	New	+$111K	﹤0.01%	1337
2016 Q3	–	Sell	-7	Closed	-$1K	–	2012
2016 Q2	$1K	Buy	+7	New	+$291	﹤0.01%	1943
2016 Q1	–	Sell	-6	Closed	-$1K	–	2122
2015 Q4	$1K	Buy	+6	New	+$298	﹤0.01%	1983

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

QS Investors's JUNO Position: Q1 2018 in Review

QS Investors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,415 shares — an estimated $110K sold.

QS Investors first reported a position in JUNO in Q4 2015 and held it in 5 quarters. The position peaked at $202K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

QS Investors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
QS Investors sold 2,415 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $110K.
QS Investors first reported a position in Juno Therapeutics, Inc. in Q4 2015 and held it in 5 quarters.
QS Investors's Juno Therapeutics, Inc. position peaked at $202K in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on QS Investors's 13F filing for Q1 2018, filed 15 May 2018.